keyword
https://read.qxmd.com/read/37045900/therapeutic-effects-of-polydeoxyribonucleotide-in-an-in-vitro-neuronal-model-of-ischemia-reperfusion-injury
#21
JOURNAL ARTICLE
Seongmoon Jo, Ahreum Baek, Yoonhee Cho, Sung Hoon Kim, Dawoon Baek, Jihye Hwang, Sung-Rae Cho, Hyun Jung Kim
Polydeoxyribonucleotide (PDRN) is an agonist that selectively stimulates adenosine A2A receptor (ADORA2A), which suppresses inflammatory responses. Ischemia/reperfusion (I/R) injury plays a major role in the pathogenesis of ischemic stroke by inducing neuroinflammation. Therefore, this study aimed to investigate the therapeutic effects of PDRN in an in vitro I/R injury model. The in vitro model was established with differentiated Neuro-2a cells under oxygen and glucose deprivation condition. The cells were treated with PDRN for 24 h under reoxygenation condition...
April 12, 2023: Scientific Reports
https://read.qxmd.com/read/36969699/multi-modulation-of-immune-inflammatory-response-using-bioactive-molecule-integrated-plga-composite-for-spinal-fusion
#22
JOURNAL ARTICLE
Hye Yeong Lee, Da-Seul Kim, Gwang Yong Hwang, Jun-Kyu Lee, Hye-Lan Lee, Ji-Won Jung, Sae Yeon Hwang, Seung-Woon Baek, Sol Lip Yoon, Yoon Ha, Keung Nyun Kim, Inbo Han, Dong Keun Han, Chang Kyu Lee
Despite current developments in bone substitute technology for spinal fusion, there is a lack of adequate materials for bone regeneration in clinical applications. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is commercially available, but a severe inflammatory response is a known side effect. Bone graft substitutes that enhance osteogenesis without adverse effects are needed. We developed a bioactive molecule-laden PLGA composite with multi-modulation for bone fusion. This bioresorbable composite scaffold was considered for bone tissue engineering...
April 2023: Materials today. Bio
https://read.qxmd.com/read/36902012/polydeoxyribonucleotide-in-the-treatment-of-tendon-disorders-from-basic-science-to-clinical-practice-a-systematic-review
#23
REVIEW
Davide Bizzoca, Giovanni Brunetti, Lorenzo Moretti, Andrea Piazzolla, Giovanni Vicenti, Francesco Luca Moretti, Giuseppe Solarino, Biagio Moretti
Polydeoxyribonucleotide (PDRN) is a proprietary and registered drug with several beneficial effects, including tissue repairing, anti-ischemic action, and anti-inflammatory properties. The present study aims to summarize the current evidence about PRDN's clinical effectiveness in the management of tendon disorders. From January 2015 to November 2022, OVID-MEDLINE® , EMBASE, Cochrane Library, SCOPUS, Web of Science, Google Scholar and PubMed were searched to identify relevant studies. The methodological quality of the studies was evaluated, and relevant data were extracted...
February 26, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36768255/efficacy-of-polydeoxyribonucleotide-in-promoting-the-healing-of-diabetic-wounds-in-a-murine-model-of-streptozotocin-induced-diabetes-a-pilot-experiment
#24
JOURNAL ARTICLE
Jiyoung Yun, SaeGwang Park, Ha Young Park, Kyung Ah Lee
We assessed the efficacy of polydeoxyribonucleotide (PDRN) in accelerating the healing of diabetic wounds in a murine model of streptozotocin (STZ)-induced diabetes. After the creation of diabetic wounds, the mice of the PDRN SC, PDRN IP and PBS groups received a subcutaneous, an intra-peritoneal injection of PDRN and a subcutaneous injection of PBS, respectively. After euthanasia, time-dependent changes in the wound diameter and histologic scores were measured and vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1) and collagen types I and III were assessed for their expression levels...
January 18, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36684531/polydeoxyribonucleotide-ameliorates-alcoholic-liver-injury-though-suppressing-phosphatidylinositol-3-kinase-protein-kinase-b-signaling-pathway-in-mice
#25
JOURNAL ARTICLE
Young-A Cho, Il-Gyu Ko, Jun-Jang Jin, Lakkyong Hwang, Sang-Hoon Kim, Jung Won Jeon, Myoung Joo Yang, Chang-Ju Kim
Polydeoxyribonucleotide (PDRN), which is adenosine A2A receptor agonist, facilitates healing and inhibits inflammation and apoptosis. The effect of PDRN on alcoholic liver injury (ALI) was evaluated focusing on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. The mice were given daily oral administration of 50% ethanol at a dose of 4 g/kg during 8 weeks. After 4 weeks of alcohol intake, 200 μL of normal saline containing 8-mg/kg PDRN was intraperitoneally administered 3 times a week for 4 weeks...
December 2022: Journal of Exercise Rehabilitation
https://read.qxmd.com/read/36559156/plla-composites-combined-with-delivery-system-of-bioactive-agents-for-anti-inflammation-and-re-endothelialization
#26
JOURNAL ARTICLE
Seung-Woon Baek, Da-Seul Kim, Duck Hyun Song, Semi Lee, Jun-Kyu Lee, So-Yeon Park, Jun Hyuk Kim, Tae-Hyung Kim, Chun Gwon Park, Dong Keun Han
The development of a biodegradable vascular scaffold (BVS) for the treatment of cardiovascular diseases (CVDs) still requires some improvement. Among them, re-endothelialization and anti-inflammation are clinically important to restore vascular function. In this study, we proposed a coating system to deliver hydrophilic bioactive agents to BVS using nanoemulsion and drop-casting methods. The poly(L-lactide) (PLLA) scaffold containing magnesium hydroxide (MH) was coated on the surface with bioactive molecules such as polydeoxyribonucleotide (PDRN), L-arginine (Arg, R), and mesenchymal stem cell-derived extracellular vesicles (EVs)...
November 30, 2022: Pharmaceutics
https://read.qxmd.com/read/36479198/corrigendum-pharmacological-activity-and-clinical-use-of-pdrn
#27
Francesco Squadrito, Alessandra Bitto, Natasha Irrera, Gabriele Pizzino, Giovanni Pallio, Letteria Minutoli, Domenica Altavilla
[This corrects the article DOI: 10.3389/fphar.2017.00224.].
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36468479/the-impact-of-polydeoxyribonucleotide-on-early-bone-formation-in-lateral-window-sinus-floor-elevation-with-simultaneous-implant-placement
#28
JOURNAL ARTICLE
Dongseob Lee, Jungwon Lee, Ki-Tae Koo, Yang-Jo Seol, Yong-Moo Lee
PURPOSE: The aim of this study was to evaluate the impact of polydeoxyribonucleotide (PDRN) on histologic outcomes when implant placement and lateral sinus floor elevation are performed simultaneously. METHODS: Three bimaxillary premolars (P2, P3, and P4) were extracted from 4 beagle dogs 2 months before lateral sinus floor elevation. After lateral elevation of the sinus membrane, each sinus was allocated to either the test or control group. Sinuses underwent either 1) collagenated synthetic bone graft with PDRN following lateral sinus floor elevation (test group) or 2) collagenated synthetic bone graft without PDRN after lateral sinus floor elevation (control group)...
September 29, 2022: Journal of Periodontal & Implant Science
https://read.qxmd.com/read/36467092/corrigendum-polydeoxyribonucleotide-an-adenosine-a2-a-receptor-agonist-preserves-blood-testis-barrier-from-cadmium-induced-injury
#29
Francesco Squadrito, Antonio Micali, Mariagrazia Rinaldi, Natasha Irrera, Herbert Marini, Domenico Puzzolo, Antonina Pisani, Cesare Lorenzini, Andrea Valenti, Rosaria Laurà, Antonino Germanà, Alessandra Bitto, Gabriele Pizzino, Giovanni Pallio, Domenica Altavilla, Letteria Minutoli
[This corrects the article DOI: 10.3389/fphar.2016.00537.].
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36438841/corrigendum-adenosine-receptor-stimulation-by-polydeoxyribonucleotide-improves-tissue-repair-and-symptomology-in-experimental-colitis
#30
Giovanni Pallio, Alessandra Bitto, Gabriele Pizzino, Federica Galfo, Natasha Irrera, Francesco Squadrito, Giovanni Squadrito, Socrate Pallio, Giuseppe P Anastasi, Giuseppina Cutroneo, Antonio Macrì, Domenica Altavilla
[This corrects the article DOI: 10.3389/fphar.2016.00273.].
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36408237/corrigendum-activation-of-a2a-receptor-by-pdrn-reduces-neuronal-damage-and-stimulates-wnt-%C3%AE-catenin-driven-neurogenesis-in-spinal-cord-injury
#31
Natasha Irrera, Vincenzo Arcoraci, Federica Mannino, Giovanna Vermiglio, Giovanni Pallio, Letteria Minutoli, Gianluca Bagnato, Giuseppe Pio Anastasi, Emanuela Mazzon, Placido Bramanti, Francesco Squadrito, Domenica Altavilla, Alessandra Bitto
[This corrects the article DOI: 10.3389/fphar.2018.00506.].
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36408231/corrigendum-adenosine-receptor-stimulation-improves-glucocorticoid-induced-osteoporosis-in-a-rat-model
#32
Gabriele Pizzino, Natasha Irrera, Federica Galfo, Giacomo Oteri, Marco Atteritano, Giovanni Pallio, Federica Mannino, Angelica D'Amore, Enrica Pellegrino, Federica Aliquò, Giuseppe P Anastasi, Giuseppina Cutroneo, Francesco Squadrito, Domenica Altavilla, Alessandra Bitto
[This corrects the article DOI: 10.3389/fphar.2017.00558.].
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/36372498/a-chitosan-derivative-crosslinked-hydrogel-with-controllable-release-of-polydeoxyribonucleotides-for-wound-treatment
#33
JOURNAL ARTICLE
Yanzhen Sun, Xiaodong Jing, Yang Liu, Bing Yu, Hao Hu, Hailin Cong, Youqing Shen
Nucleic acid-based agents have advantages in therapeutic efficacy and biological safety. However, due to its facile degradability, it lacks an effective route of administration in wound treatment. Designing smart hydrogels for the spatiotemporally controllable delivery of nucleic acids is of great significance for clinical applications. Here, a near-infrared (NIR)-responsive nanocomposite hydrogel was prepared using methyl methacrylate (GMA)-modified chitosan as the macromolecular cross-linker, N-isopropylacrylamide (NIPAAm) as the backbone, and molybdenum disulfide nanosheets (MoS2 NSs) as the nanocomponents...
January 15, 2023: Carbohydrate Polymers
https://read.qxmd.com/read/36362312/effect-of-polydeoxyribonucleotide-pdrn-treatment-on-corneal-wound-healing-in-zebrafish-danio-rerio
#34
JOURNAL ARTICLE
Shan Lakmal Edirisinghe, Chamilani Nikapitiya, S H S Dananjaya, Jungho Park, Dukgyu Kim, Dongrack Choi, Mahanama De Zoysa
This study aimed to develop a corneal epithelial injury model in zebrafish (Danio rerio) and investigate the effectiveness of polydeoxyribonucleotide (PDRN) treatment on in vivo corneal epithelial regeneration and wound healing. Chemical injury to zebrafish cornea was produced by placing a small cotton swab containing 3% acetic acid solution. PDRN treatment was performed by immersing corneal-injured zebrafish in water containing PDRN (2 mg/mL) for 10 min at 0, 24, 48, and 72 h post-injury (hpi). The level of corneal healing was evaluated by fluorescein staining, histological examination, transcriptional profiling, and immunoblotting techniques...
November 4, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36361932/involvement-of-hypoxia-inducible-factor-1-%C3%AE-in-experimental-testicular-ischemia-and-reperfusion-effects-of-polydeoxyribonucleotide-and-selenium
#35
JOURNAL ARTICLE
Pietro Antonuccio, Giovanni Pallio, Herbert Ryan Marini, Natasha Irrera, Carmelo Romeo, Domenico Puzzolo, Jose Freni, Giuseppe Santoro, Igor Pirrotta, Francesco Squadrito, Letteria Minutoli, Antonio Micali
Polydeoxyribonucleotide (PDRN) is an agonist of the A2A adenosine receptor derived from salmon trout sperm. Selenium (Se) is a trace element normally present in the diet. We aimed to investigate the long-term role of PDRN and Se, alone or in association, after ischemia-reperfusion (I/R) in rats. The animals underwent 1 h testicular ischemia followed by 30 days of reperfusion or a sham I/R and were treated with PDRN or Se alone or in association for 30 days. I/R significantly increased hypoxia-inducible factor 1-α (HIF-1α) in Leydig cells, malondialdehyde (MDA), phosphorylated extracellular signal-regulated kinases 1/2 (pErk 1/2), and apoptosis decreased testis weight, glutathione (GSH), testosterone, nuclear factor erythroid 2-related factor 2 (Nrf2), induced testicular structural changes, and eliminated HIF-1α spermatozoa positivity...
October 29, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36337843/combination-therapy-of-polydeoxyribonucleotide-and-microcurrent-in-muscle-regeneration-on-cast-induced-muscle-atrophy-in-rabbit
#36
JOURNAL ARTICLE
Dong Rak Kwon, Yong Suk Moon, Do Yun Kwon
Background: The aim of this study was to evaluate how polydeoxyribonucleotide (PDRN) and microcurrent therapy (MT) functioned synergistically in a cast-immobilized rabbit model with an atrophied calf muscle. Methods: At the age of 12 weeks, 32 male New Zealand rabbits were enrolled in four groups. After 2 weeks of cast-immobilization, 4 procedures were performed on atrophied calf muscle [weekly two injections normal saline 0.2 ml injection group 1 (G1-NS), weekly two injections 0...
2022: BioMed Research International
https://read.qxmd.com/read/36111024/the-effects-of-treatment-using-polydeoxyribonucleotide-through-extracorporeal-shock-wave-therapy-synergic-regeneration-effects-on-atrophied-calf-muscles-in-immobilized-rabbits
#37
JOURNAL ARTICLE
Kang Lip Kim, Gi Young Park, Yong Suk Moon, Dong Rak Kwon
Background: This study aimed to examine the synergic effects of polydeoxyribonucleotide (PDRN) through extracorporeal shock wave therapy (ESWT) on atrophied calf muscles in cast-immobilized rabbit models. Methods: Twenty male New Zealand rabbits (aged 12 weeks) were allocated into four groups. Four types of procedures [0.7 mL normal saline to Group 1 (G1-NS); 0.7 mL PDRN to Group 2 (G2-PDRN); ESWT to Group 3 (G3-ESWT); and 0.7 mL PDRN with ESWT to Group 4 (G4-PDRN + ESWT)] were injected to the atrophied calf muscles of the rabbits after two weeks of cast immobilization...
August 2022: Annals of Translational Medicine
https://read.qxmd.com/read/36070635/a-progressively-dual-reconstruction-network-for-plane-wave-beamforming-with-both-paired-and-unpaired-training-data
#38
JOURNAL ARTICLE
Junling Gao, Lei Xu, Qin Zou, Bo Zhang, Diya Wang, Mingxi Wan
High-frame-rate plane wave (PW) imaging suffers from unsatisfactory image quality due to the absence of focus in transmission. Although coherent compounding from tens of PWs can improve PW image quality, it in turn results in a decreased frame rate, which is limited for tracking fast moving tissues. To overcome the trade-off between frame rate and image quality, we propose a progressively dual reconstruction network (PDRN) to achieve adaptive beamforming and enhance the image quality via both supervised and transfer learning in the condition of single or a few PWs transmission...
August 28, 2022: Ultrasonics
https://read.qxmd.com/read/35956878/the-combination-of-niacinamide-vitamin-c-and-pdrn-mitigates-melanogenesis-by-modulating-nicotinamide-nucleotide-transhydrogenase
#39
JOURNAL ARTICLE
Hyun Jun Park, Kyung-A Byun, Seyeon Oh, Hyoung Moon Kim, Moon Suk Chung, Kuk Hui Son, Kyunghee Byun
Nicotinamide nucleotide transhydrogenase (NNT) is involved in decreasing melanogenesis through tyrosinase degradation induced by cellular redox changes. Nicotinamide is a component of coenzymes, such as NAD+ , NADH, NADP+ , and NADPH, and its levels are modulated by NNT. Vitamin C and polydeoxyribonucleotide (PDRN) are also known to decrease skin pigmentation. We evaluated whether a mixture of nicotinamide, vitamin C, and PDRN (NVP-mix) decreased melanogenesis by modulating mitochondrial oxidative stress and NNT expression in UV-B-irradiated animals and in an in vitro model of melanocytes treated with conditioned media (CM) from UV-B-irradiated keratinocytes...
August 2, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/35713247/early-postoperative-injections-of-polydeoxyribonucleotide-prevent-hypertrophic-scarring-after-thyroidectomy-a-randomized-controlled-trial
#40
RANDOMIZED CONTROLLED TRIAL
Bo Ri Kim, Soon Hyo Kwon, Jee Woo Kim, Woo-Jin Jeong, Wonjae Cha, Young Ho Jung, Jung-Im Na, Chang-Hun Huh, Jung-Won Shin
Objective: Polydeoxyribonucleotide (PDRN) is known to enhance wound healing, but there has been no clinical trial investigating the effect of PDRN on scar prevention in surgical wounds. This study aimed to evaluate the efficacy of PDRN administration in preventing postoperative scars. Approach: In this randomized controlled trial (NCT05149118), 44 patients who underwent open thyroidectomy were randomly assigned to the PDRN treatment or untreated control group. Only patients in the treatment group received two consecutive injections of PDRN 1 and 2 days after surgery...
July 2023: Advances in Wound Care
keyword
keyword
102149
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.